Open-label, randomized, two-parallel-arm, single center study to designed to evaluate azathioprine versus adalimumab after induction of tacrolimus in refractory ulcerative colitis therapy
Not Applicable
- Conditions
- lcerative Colitis
- Registration Number
- JPRN-UMIN000030988
- Lead Sponsor
- Sakura Medical Center, Toho university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 53
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who are contraindicated of tacrolimus, azathioprine or adalimumab Female patients who are in lactation or desire to bear children Patients less than 15 years old Patients who do not consent to the trial Patients who had malignancy Patients who had intestinal resection within 6 months Patients who are short-bowel syndrome Patients who are not appropriate to participate to the trial
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method